Source: International Congress 2015 – Latent TB infection and screening
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Connie G.M. Erkens (The Hague, Netherlands), Connie Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Gerard De Vries, Susan Van den Hof. The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands. Eur Respir J 2015; 46: Suppl. 59, 1446

Member's Comments

No comment yet.

Related content which might interest you: Latent TB infection in health care TB workers Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 The changing indications for IGRA testing and impact on TB services in a UK district general hospital Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Five-year follow-up in healthcare workers tested with tuberculin skin test and interferon gamma assay Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Management of tuberculosis (TB) at a district general hospital: An audit of practice Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Home based tuberculosis (TB) care program Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015 Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Investigation of pulmonary TB cluster amongst health care workers involving a neonatal intensive care unit Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Cross sectional screening of health care workers (HCW) at a regional chest clinic with an interferon gamma release assay (IGRA): First report from Sri Lanka Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Safety of two step tuberculin skin test (TST) in the screening of healthcare workers for latent TB infection (LTBI) Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Do we need to screen for latent TB when initiating a methotrexate treatment? Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 The cost of tuberculosis in Denmark Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Active case finding of tuberculosis, Tomsk (Russia) Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Prevalence of latent tuberculosis infection among household contacts and community controls in South India Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Low real-world utility of IGRA when screening for LTBI in a low incidence setting Source: International Congress 2015 – Screening strategies in TB Year: 2015 Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015